Financial Data and Key Metrics Changes - The company reported FFO as adjusted of $0.46 per share and AFFO of $0.42 per share, with year-to-date portfolio same-store growth of 3.8% [12][18] - Cash NOI increased by 9.4% for the quarter, driven by strong performance in the CCRC portfolio [13][18] Business Line Data and Key Metrics Changes - CCRC portfolio experienced a 150 basis points year-over-year occupancy gain, with sequential occupancy up 70 basis points [9][14] - Outpatient medical leasing demand remains favorable, with 1.2 million sq ft of leases executed during the quarter and total occupancy up 10 basis points at 91% [14][18] - Lab leasing saw 339,000 sq ft of leases executed, with total occupancy at 81% and a positive 5% releasing spread on renewals [16][18] Market Data and Key Metrics Changes - The leasing pipeline has doubled to 1.8 million sq ft since the beginning of the year, with a favorable mix of new and renewal leases [17][22] - The company is experiencing increased demand from tech and AI-based companies, contributing to a strengthening demand profile [17][43] Company Strategy and Development Direction - The company aims to recycle outpatient sale proceeds into higher return lab opportunities, with potential proceeds of $1 billion or more from asset sales [7][18] - The internalization of property management allows for quicker deployment of technology and deeper tenant relationships, enhancing growth opportunities [5][11] - The company is focused on maintaining a flexible balance sheet to pursue strategic investments and fund portfolio growth [18][75] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in the recovery of the life science sector, with leading indicators turning positive and a strong pipeline of leasing activity [4][17] - The company anticipates a decline in occupancy over the next few months but believes it will reach a bottom before starting to recover [8][17] - Management highlighted the importance of the outpatient medical sector, which has shown consistent positive NOI growth over the years [26][27] Other Important Information - The company has completed $158 million of asset sales and loan repayments year-to-date, with an additional $204 million of dispositions under a purchase and sale agreement [18][19] - The company is advancing its technology initiatives to create a tech-enabled platform aimed at streamlining operations and expanding tenant services [10][11] Q&A Session Summary Question: Can you elaborate on the lab leasing pipeline and its changes? - Management noted that the lab leasing pipeline has doubled, with a favorable mix of new and renewal leases driven by improved sentiment in the sector [22][23] Question: What are the potential opportunities for capital recycling? - Management indicated that outpatient medical has been a strong business, and they are looking to take advantage of strong demand for assets to sell less strategic properties [25][26] Question: How does the company view tenant risk and the current market sentiment? - Management reported a decrease in tenant risk exposure and expressed confidence in the ability of tenants to raise capital, improving overall sentiment [38][41] Question: What is the expected timeline for occupancy recovery? - Management expects occupancy to trend down to the high 70% range before starting to recover, with a focus on maintaining a strong leasing pipeline [76][93]

Financial Data and Key Metrics Changes - The company reported FFO as adjusted of $0.46 per share and AFFO of $0.42 per share, with year-to-date portfolio same-store growth of 3.8% [12][18] - Cash NOI increased by 9.4% for the quarter [13] - The company ended the third quarter with a net debt to adjusted EBITDA ratio of 5.3x and $2.7 billion of liquidity [17] Business Line Data and Key Metrics Changes - CCRC portfolio delivered strong performance with NOI up more than 50% since acquiring the joint venture interest, including double-digit growth this year [9] - Outpatient medical executed 1.2 million sq ft of leases during the quarter, achieving 3% escalators or above on executions and positive cash releasing spreads of 5.4% [14] - Lab leasing saw 339,000 sq ft of leases executed, with total occupancy at 81% and positive 5% releasing spread on renewals [16] Market Data and Key Metrics Changes - The leasing pipeline has doubled to 1.8 million sq ft since the beginning of the year, with a favorable mix of new and renewal leases [16][22] - The company is experiencing increased demand from tech and AI-based companies, contributing to a strengthening demand profile [17][43] Company Strategy and Development Direction - The company aims to recycle outpatient sale proceeds into higher return lab opportunities, with a focus on strategic investments and disciplined capital allocation [7][18] - The internalization of property management allows for quicker deployment of technology and deeper tenant relationships, enhancing growth opportunities [5][11] - The company is focused on maintaining a tech-enabled platform to streamline operations and expand tenant services [10][11] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in the recovery of the outpatient sector, citing positive leading indicators and a strong pipeline for leasing [4][7] - The company anticipates a decline in occupancy in the short term but expects to reach a bottom and begin recovery thereafter [8][17] - Management highlighted the importance of the recent positive regulatory environment and its impact on tenant sentiment and capital raising [64] Other Important Information - The company has completed $158 million of asset sales and loan repayments year-to-date, with an additional $204 million of dispositions under a purchase and sale agreement [18][19] - The company is exploring various opportunities for capital recycling, including outpatient medical, life science investments, and potential share repurchases [57] Q&A Session Summary Question: Can you elaborate on the lab leasing pipeline and what's changed? - Management noted that the pipeline has doubled, with a favorable mix of new and renewal leases driven by improved sentiment in the sector [22][23] Question: What are the potential opportunities for the $1 billion in outpatient medical sales? - Management indicated that outpatient medical has been a strong business, and they plan to take advantage of strong demand for assets while exploring higher return opportunities in life sciences [25][26] Question: How does the company view tenant risk and the current tenant base? - Management reported a meaningful reduction in tenant exposure and expressed confidence in the ability of tenants to raise capital in the current environment [38][41] Question: What is the expected timeline for occupancy recovery? - Management expects occupancy to trend down to the high 70% range before beginning to recover, with a focus on maintaining strong tenant relationships [76][77] Question: How does M&A activity impact tenant space needs? - Management indicated that M&A can lead to increased demand for space, depending on the nature of the acquisition [96]

Brookdale Overview - Brookdale operates 645 senior living communities across 41 states[8] - The company has the capacity to serve approximately 58,000 residents[8] - 94% of senior living resident fees are private pay[8] Financial Performance and Guidance - Second quarter Adjusted Free Cash Flow improved by $25 million year-over-year, reaching $20 million[33] - The company anticipates portfolio ownership to increase to 75% by the end of 2025[20] - 2025 Adjusted EBITDA guidance increased by $5 million at the midpoint, with a range of $445 to $455 million[37, 36] - Adjusted Free Cash Flow for 2025 is projected to be between $30 to $50 million[36] Occupancy and RevPAR - Consolidated weighted average occupancy grew by 200 bps in the second quarter year-over-year[33] - July 2025 month-end consolidated occupancy reached 82.6%, marking eight consecutive months of acceleration[33] - The company expects RevPAR YOY Growth of 5.25% to 6.00% for 2025[36] Capital Structure - 72% of the company's debt is fixed rate debt[42] - 88% of the company's debt is non-recourse property-level mortgage financings[42]